» Articles » PMID: 23257897

Radiation-related Mortality from Heart Disease and Lung Cancer More Than 20 Years After Radiotherapy for Breast Cancer

Overview
Journal Br J Cancer
Specialty Oncology
Date 2012 Dec 22
PMID 23257897
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiation-related heart disease and lung cancer can occur following radiotherapy for breast cancer but the duration of any mortality risk is uncertain.

Methods: Mortality ratios, by laterality of breast cancer, were estimated using Poisson regression for 558 871 women recorded with breast cancer during 1973-2008 in the Surveillance, Epidemiology and End Results (SEER) cancer registries and followed until 01 January 2009.

Results: For women diagnosed with breast cancer during 1973-1982 and given radiotherapy shortly afterwards, the cardiac mortality ratios, left-sided vs right-sided, were 1.19 (1.03-1.38), 1.35 (1.05-1.73), 1.64 (1.26-2.14) and 1.90 (1.52-2.37) at <10, 10-14, 15-19 and 20+ years since diagnosis (2p for trend: <0.001). The lung cancer mortality ratios, ipsilateral vs contralateral, in these women were 1.05 (0.57-1.94), 2.04 (1.28-3.23) and 3.87 (2.19-6.82) at <10, 10-19 and 20+ years, respectively, (2p for trend: 0.002). For women irradiated during 1983-92 there was evidence of radiation-related mortality for lung cancer, but not for heart disease. For women irradiated since 1993 there is, as yet, little evidence of any radiation-related mortality.

Conclusion: In this population, the radiation-related risks were larger in the third decade after exposure than during the first two decades.

Citing Articles

Enhancing positioning accuracy in adjuvant radiotherapy for left breast cancer using cervical-thoracic integrated bracket combined with deep inspiration breath holding.

Wan B, Liu Y, Ge Y, Liu F, Zhao R, Li T Thorac Cancer. 2024; 15(36):2540-2550.

PMID: 39520201 PMC: 11669448. DOI: 10.1111/1759-7714.15484.


Evaluation of early cardiotoxicity in HER2-positive breast cancer patients receiving radiotherapy and concurrent trastuzumab.

Aslan D, Ozoner S, Inanc M, Yildiz O, Inanc M Ir J Med Sci. 2024; 194(1):7-18.

PMID: 39495473 DOI: 10.1007/s11845-024-03835-x.


Evaluation of helical tomotherapy as an alternative for left-sided breast cancer patients not compliant with deep inspiration breath hold.

Kuru O, Ozan Goksel E, Volkan Demircan N, Sengoz M Tech Innov Patient Support Radiat Oncol. 2024; 31:100268.

PMID: 39247163 PMC: 11380380. DOI: 10.1016/j.tipsro.2024.100268.


Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours.

Barcellini A, Rordorf R, Dusi V, Fontana G, Pepe A, Vai A Strahlenther Onkol. 2024; 200(12):1080-1087.

PMID: 39212688 DOI: 10.1007/s00066-024-02270-2.


Cardiac doses with deep inspiration breath hold in breast cancer radiotherapy: direct comparison between WBI, PBI, and interstitial APBI.

Sirak I, Pohankova D, Kasaova L, Hodek M, Motycka P, Asqar A Rep Pract Oncol Radiother. 2024; 29(2):155-163.

PMID: 39143972 PMC: 11321770. DOI: 10.5603/rpor.99907.


References
1.
Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

2.
Solin L, Fowble B, Martz K, Goodman R, Hanks G . Results of the 1983 patterns of care process survey for definitive breast irradiation. Int J Radiat Oncol Biol Phys. 1991; 20(1):105-11. DOI: 10.1016/0360-3016(91)90145-t. View

3.
Vandenbroucke J . When are observational studies as credible as randomised trials?. Lancet. 2004; 363(9422):1728-31. DOI: 10.1016/S0140-6736(04)16261-2. View

4.
Taylor C, Povall J, McGale P, Nisbet A, Dodwell D, Smith J . Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008; 72(2):501-7. DOI: 10.1016/j.ijrobp.2007.12.058. View

5.
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View